Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | INCY | TMO |
|---|
| Close | 124.75 | 648.43 |
| Market Cap | $25.3B | $240B |
| 1M | +1.01% | +10.75% |
| P/E (TTM) | 15.3 | 34.4 |
| Forward P/E | 18.1 | 21.8 |
| P/E 5-Yr Percentile | 8 | 65 |
| P/S | 4.2 | 5.2 |
| P/B | 3.9 | 4.6 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $1.3B | $12.0B |
| Revenue YoY | +20.9% | +10.5% |
| Gross Margin | 91.8% | — |
| Latest Quarter EPS | 1.47 | 4.68 |
| Avg Post-Earnings Move | ±1.7% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 0.00% | 2.36% |
| 90-Day Net Insider Buying | −$15.4M | −$38.9M |
INCY · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
